As for treatment guidelines, SD-NSCLC is treated in accordance with guidelines of NSCLC, but several studies indicated detrimental effect of SMARCA4 alteration in prognosis (Alessi et al. 2021; Herpel et al. 2017; Velut et al. 2022). The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.